NCT02715024View on ClinicalTrials.gov

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Lower Urinary Tract SymptomsOveractive BladderBenign Prostatic Hyperplasia (BPH)
Interventions
DRUG

Tamsulosin

Oral

DRUG

Solifenacin

Oral

Trial Locations (1)

Unknown

Site, Taipei

All Listed Sponsors
lead

Astellas Pharma Taiwan, Inc.

INDUSTRY

NCT02715024 - Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms | Biotech Hunter | Biotech Hunter